Global Bio Pharma Conference Group in partnering with
Florida International University presents First Global Stem
Cell Workshop series in India.
Current developments in stem cell commercialization: “A
global perspective on International Regulatory and Industry
workshop Series in Mumbai, Ahmedabad, Bangalore & Pune
during August 24 -27, 2010
The First Global Stem Cell Workshop Speakers are World
renowned experts representing Stem Cell Industries from USA,
and US-FDA and Indian authorities.
Stem cell research holds great promise for improving human
health by control of degenerative diseases and restoration
of damage to organs by various injuries.
Research on stem cells/ lines and their applications have
considerable commercial value.
Stem cell therapy has been described as the next revolution
in medicine. Therapeutic stem cell applications have been
proposed to address a wide range of health care needs.
India prepared to take advantage of stem cell
Indian stem cell centers prepared to bring highest quality
standards to comply with US-FDA
and EMEA regulations?
the safety concerns in long term? How do we overcome these
any disruptive/breakthrough stem cell technologies out
the current developments in Stem Cell commercialization,
Global BioPharma Conference Group, USA, a non-profit
organization, in partnership with Florida International
University, USA is organizing a series of first Global Stem
Cell Workshops in four cities in India in August 2010.
The workshops will focus on current challenges and
opportunities in the Stem cell application, therapy,
commercialization and regulations.
The area of stem cell research being new and associated with
rapid scientific developments and complicated ethical,
social and legal issues requires extra care and expertise in
scientific and ethical evaluation of research proposals and
The stem cell applications open new business paradigm for
entrepreneurs, investors, VCs, Private Equity funds, funding
Institutions, hospitals and biotechnology companies and big
The one day workshop series will focus on global regulatory
and industry interface besides tracking developments in
therapeutic applications, strategic and regulatory
guidelines and requirements.
GBPCG is proud to bring to India some of the most
distinguished personalities in regulatory authorities such
as USFDA, stem cell industry experts and principal
investigators for this workshop series.
Who should attend?
Given the broad application potential of stem-cell-based
technology, the workshops will be of interest to the life
science industry, in particular, to individuals in the
biotechnology, pharmaceutical and medical device markets.
It will be of interest to manufacturers of reagents and
tools that support the research and development of
stem-cell-based products and services.
Also, Equipment Vendors, cGMP Facility builders, Principle
Investigators - Conducting Clinical Trials in Stem Cells,
Regenerative Medicine, Gene Therapy, Personalized Medicine
will benefit from the workshop.
Professionals involved in stem cell research, development,
and commercialization as well as doctors and hospitals
involved in stem cell therapy will find the workshop useful
Venture capitalist, insurance companies, funding
institutions keen on potential opportunities in
stem-cell-based investment will find great opportunities for
their future ventures.
Reasons to Attend the workshop:-
1. This is the first of its kind event in India on Stem Cell
R & D, and Commercialization.
2. The workshop will bring together industry experts and
officials from high level regulatory
3. It will provide an opportunity for Indian industry to
interact with experts on regulatory issues
during the interactive panel discussion.
4. Networking opportunities amongst industry professionals.
5. It will enhance business development, East-West
synergies, partnership, JVs, collaborations,
Copyright 2004-2010, Global Bio Pharma Conference Group.